Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

University of Illinois at Chicago163 enrolled

Overview

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

Study Type

OBSERVATIONAL

Enrollment

163

Conditions

Subarachnoid Hemorrhage Intracerebral Hemorrhage

Interventions

Nicardipine and NiprideDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18-70 years old (inclusive) * Admission to NSICU with a diagnosis of SAH or ICH Exclusion Criteria: * Patients who are admitted \>48 hours after SAH or ICH * Readmission or second SAH * Readmission or second ICH * Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage * Women who are pregnant

Locations (1)

University of Illinois at Chicago, UIC

Chicago, Illinois, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.